Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Neuromodulation and Neurostimulation Pain Management Devices Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4614984
    • |
  • 02 September, 2024
    • |
  • Global
    • |
  • 88 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Medical Devices & Consumables

Pain management is a branch of medical science, which eases the suffering of patients who suffer from chronic pain. Acute pain has sudden onset of action, whereas chronic pain persists for a longer duration, which leads to need for its management. Neuromodulation and Neurostimulation Pain Management Devices are medical devices that are used in management of different types of pain such as neuropathic pain, cancer pain, Facial & Migraine Pain, Musculoskeletal Pain, and others.
According to our (Global Info Research) latest study, the global Neuromodulation and Neurostimulation Pain Management Devices market size was valued at US$ 2177 million in 2023 and is forecast to a readjusted size of USD 3360 million by 2030 with a CAGR of 6.3% during review period.
Spinal cord stimulators, transcutaneous electrical nerve stimulation devices, analgesic infusion pumps, and ablation devices are various types of pain management devices available in the market. The growth of the global pain management devices market is driven by increase in geriatric population, rise in prevalence of chronic pain, surge in geriatric population, surge in awareness among people toward pain management devices, improved R&D investment to develop innovative products, and launch of innovative products. In addition, increase in demand for pain management devices among the developing countries and rise in adoption of pain management devices for management of chronic pain are other factors that contribute toward the growth of the market. Furthermore, untapped potential offered by developing economies present lucrative opportunities for market expansion during the forecast period. However, hypersensitivity reactions and post-operative infections caused due to use of these devices limit their adoption, which hampers the growth of the market. Moreover, these devices are usually used as second line of treatment in patients with chronic pain who become resistant to drug therapy, which limits the growth of the global pain management devices market.
This report is a detailed and comprehensive analysis for global Neuromodulation and Neurostimulation Pain Management Devices market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Neuromodulation and Neurostimulation Pain Management Devices market size and forecasts, in consumption value ($ Million), 2019-2030
Global Neuromodulation and Neurostimulation Pain Management Devices market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Neuromodulation and Neurostimulation Pain Management Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Neuromodulation and Neurostimulation Pain Management Devices market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neuromodulation and Neurostimulation Pain Management Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neuromodulation and Neurostimulation Pain Management Devices market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic Plc, Boston Scientific Corporation, Pfizer Inc. (Hospira Inc.), Johnson & Johnson (Codman And Shurtleff, Inc.), Stryker Corporation, Kimberly-Clark Corporation (Baylis Medical), Colfax Corporation (Djo Global Llc), Abbott Laboratories, B Braun Melsungen Ag, Baxter International Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Neuromodulation and Neurostimulation Pain Management Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Neuromodulation and Neurostimulation Pain Management Devices market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Spinal Cord Stimulators
Transcutaneous Electrical Nerve Stimulation (TENS) Devices
Market segment by Application
Neuropathic Pain
Cancer Pain
Facial & Migraine Pain
Musculoskeletal Pain
Others
Market segment by players, this report covers
Medtronic Plc
Boston Scientific Corporation
Pfizer Inc. (Hospira Inc.)
Johnson & Johnson (Codman And Shurtleff, Inc.)
Stryker Corporation
Kimberly-Clark Corporation (Baylis Medical)
Colfax Corporation (Djo Global Llc)
Abbott Laboratories
B Braun Melsungen Ag
Baxter International Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Neuromodulation and Neurostimulation Pain Management Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Neuromodulation and Neurostimulation Pain Management Devices, with revenue, gross margin, and global market share of Neuromodulation and Neurostimulation Pain Management Devices from 2019 to 2024.
Chapter 3, the Neuromodulation and Neurostimulation Pain Management Devices competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Neuromodulation and Neurostimulation Pain Management Devices market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Neuromodulation and Neurostimulation Pain Management Devices.
Chapter 13, to describe Neuromodulation and Neurostimulation Pain Management Devices research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Neuromodulation and Neurostimulation Pain Management Devices by Type
    • 1.3.1 Overview: Global Neuromodulation and Neurostimulation Pain Management Devices Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Neuromodulation and Neurostimulation Pain Management Devices Consumption Value Market Share by Type in 2023
    • 1.3.3 Spinal Cord Stimulators
    • 1.3.4 Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  • 1.4 Global Neuromodulation and Neurostimulation Pain Management Devices Market by Application
    • 1.4.1 Overview: Global Neuromodulation and Neurostimulation Pain Management Devices Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Neuropathic Pain
    • 1.4.3 Cancer Pain
    • 1.4.4 Facial & Migraine Pain
    • 1.4.5 Musculoskeletal Pain
    • 1.4.6 Others
  • 1.5 Global Neuromodulation and Neurostimulation Pain Management Devices Market Size & Forecast
  • 1.6 Global Neuromodulation and Neurostimulation Pain Management Devices Market Size and Forecast by Region
    • 1.6.1 Global Neuromodulation and Neurostimulation Pain Management Devices Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Neuromodulation and Neurostimulation Pain Management Devices Market Size by Region, (2019-2030)
    • 1.6.3 North America Neuromodulation and Neurostimulation Pain Management Devices Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Neuromodulation and Neurostimulation Pain Management Devices Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Neuromodulation and Neurostimulation Pain Management Devices Market Size and Prospect (2019-2030)
    • 1.6.6 South America Neuromodulation and Neurostimulation Pain Management Devices Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Neuromodulation and Neurostimulation Pain Management Devices Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Medtronic Plc
    • 2.1.1 Medtronic Plc Details
    • 2.1.2 Medtronic Plc Major Business
    • 2.1.3 Medtronic Plc Neuromodulation and Neurostimulation Pain Management Devices Product and Solutions
    • 2.1.4 Medtronic Plc Neuromodulation and Neurostimulation Pain Management Devices Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Medtronic Plc Recent Developments and Future Plans
  • 2.2 Boston Scientific Corporation
    • 2.2.1 Boston Scientific Corporation Details
    • 2.2.2 Boston Scientific Corporation Major Business
    • 2.2.3 Boston Scientific Corporation Neuromodulation and Neurostimulation Pain Management Devices Product and Solutions
    • 2.2.4 Boston Scientific Corporation Neuromodulation and Neurostimulation Pain Management Devices Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Boston Scientific Corporation Recent Developments and Future Plans
  • 2.3 Pfizer Inc. (Hospira Inc.)
    • 2.3.1 Pfizer Inc. (Hospira Inc.) Details
    • 2.3.2 Pfizer Inc. (Hospira Inc.) Major Business
    • 2.3.3 Pfizer Inc. (Hospira Inc.) Neuromodulation and Neurostimulation Pain Management Devices Product and Solutions
    • 2.3.4 Pfizer Inc. (Hospira Inc.) Neuromodulation and Neurostimulation Pain Management Devices Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Pfizer Inc. (Hospira Inc.) Recent Developments and Future Plans
  • 2.4 Johnson & Johnson (Codman And Shurtleff, Inc.)
    • 2.4.1 Johnson & Johnson (Codman And Shurtleff, Inc.) Details
    • 2.4.2 Johnson & Johnson (Codman And Shurtleff, Inc.) Major Business
    • 2.4.3 Johnson & Johnson (Codman And Shurtleff, Inc.) Neuromodulation and Neurostimulation Pain Management Devices Product and Solutions
    • 2.4.4 Johnson & Johnson (Codman And Shurtleff, Inc.) Neuromodulation and Neurostimulation Pain Management Devices Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Johnson & Johnson (Codman And Shurtleff, Inc.) Recent Developments and Future Plans
  • 2.5 Stryker Corporation
    • 2.5.1 Stryker Corporation Details
    • 2.5.2 Stryker Corporation Major Business
    • 2.5.3 Stryker Corporation Neuromodulation and Neurostimulation Pain Management Devices Product and Solutions
    • 2.5.4 Stryker Corporation Neuromodulation and Neurostimulation Pain Management Devices Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Stryker Corporation Recent Developments and Future Plans
  • 2.6 Kimberly-Clark Corporation (Baylis Medical)
    • 2.6.1 Kimberly-Clark Corporation (Baylis Medical) Details
    • 2.6.2 Kimberly-Clark Corporation (Baylis Medical) Major Business
    • 2.6.3 Kimberly-Clark Corporation (Baylis Medical) Neuromodulation and Neurostimulation Pain Management Devices Product and Solutions
    • 2.6.4 Kimberly-Clark Corporation (Baylis Medical) Neuromodulation and Neurostimulation Pain Management Devices Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Kimberly-Clark Corporation (Baylis Medical) Recent Developments and Future Plans
  • 2.7 Colfax Corporation (Djo Global Llc)
    • 2.7.1 Colfax Corporation (Djo Global Llc) Details
    • 2.7.2 Colfax Corporation (Djo Global Llc) Major Business
    • 2.7.3 Colfax Corporation (Djo Global Llc) Neuromodulation and Neurostimulation Pain Management Devices Product and Solutions
    • 2.7.4 Colfax Corporation (Djo Global Llc) Neuromodulation and Neurostimulation Pain Management Devices Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Colfax Corporation (Djo Global Llc) Recent Developments and Future Plans
  • 2.8 Abbott Laboratories
    • 2.8.1 Abbott Laboratories Details
    • 2.8.2 Abbott Laboratories Major Business
    • 2.8.3 Abbott Laboratories Neuromodulation and Neurostimulation Pain Management Devices Product and Solutions
    • 2.8.4 Abbott Laboratories Neuromodulation and Neurostimulation Pain Management Devices Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Abbott Laboratories Recent Developments and Future Plans
  • 2.9 B Braun Melsungen Ag
    • 2.9.1 B Braun Melsungen Ag Details
    • 2.9.2 B Braun Melsungen Ag Major Business
    • 2.9.3 B Braun Melsungen Ag Neuromodulation and Neurostimulation Pain Management Devices Product and Solutions
    • 2.9.4 B Braun Melsungen Ag Neuromodulation and Neurostimulation Pain Management Devices Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 B Braun Melsungen Ag Recent Developments and Future Plans
  • 2.10 Baxter International Inc.
    • 2.10.1 Baxter International Inc. Details
    • 2.10.2 Baxter International Inc. Major Business
    • 2.10.3 Baxter International Inc. Neuromodulation and Neurostimulation Pain Management Devices Product and Solutions
    • 2.10.4 Baxter International Inc. Neuromodulation and Neurostimulation Pain Management Devices Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Baxter International Inc. Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Neuromodulation and Neurostimulation Pain Management Devices Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Neuromodulation and Neurostimulation Pain Management Devices by Company Revenue
    • 3.2.2 Top 3 Neuromodulation and Neurostimulation Pain Management Devices Players Market Share in 2023
    • 3.2.3 Top 6 Neuromodulation and Neurostimulation Pain Management Devices Players Market Share in 2023
  • 3.3 Neuromodulation and Neurostimulation Pain Management Devices Market: Overall Company Footprint Analysis
    • 3.3.1 Neuromodulation and Neurostimulation Pain Management Devices Market: Region Footprint
    • 3.3.2 Neuromodulation and Neurostimulation Pain Management Devices Market: Company Product Type Footprint
    • 3.3.3 Neuromodulation and Neurostimulation Pain Management Devices Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Neuromodulation and Neurostimulation Pain Management Devices Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Neuromodulation and Neurostimulation Pain Management Devices Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Neuromodulation and Neurostimulation Pain Management Devices Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Neuromodulation and Neurostimulation Pain Management Devices Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Neuromodulation and Neurostimulation Pain Management Devices Consumption Value by Type (2019-2030)
  • 6.2 North America Neuromodulation and Neurostimulation Pain Management Devices Market Size by Application (2019-2030)
  • 6.3 North America Neuromodulation and Neurostimulation Pain Management Devices Market Size by Country
    • 6.3.1 North America Neuromodulation and Neurostimulation Pain Management Devices Consumption Value by Country (2019-2030)
    • 6.3.2 United States Neuromodulation and Neurostimulation Pain Management Devices Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Neuromodulation and Neurostimulation Pain Management Devices Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Neuromodulation and Neurostimulation Pain Management Devices Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Neuromodulation and Neurostimulation Pain Management Devices Consumption Value by Type (2019-2030)
  • 7.2 Europe Neuromodulation and Neurostimulation Pain Management Devices Consumption Value by Application (2019-2030)
  • 7.3 Europe Neuromodulation and Neurostimulation Pain Management Devices Market Size by Country
    • 7.3.1 Europe Neuromodulation and Neurostimulation Pain Management Devices Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Neuromodulation and Neurostimulation Pain Management Devices Market Size and Forecast (2019-2030)
    • 7.3.3 France Neuromodulation and Neurostimulation Pain Management Devices Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Neuromodulation and Neurostimulation Pain Management Devices Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Neuromodulation and Neurostimulation Pain Management Devices Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Neuromodulation and Neurostimulation Pain Management Devices Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Neuromodulation and Neurostimulation Pain Management Devices Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Neuromodulation and Neurostimulation Pain Management Devices Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Neuromodulation and Neurostimulation Pain Management Devices Market Size by Region
    • 8.3.1 Asia-Pacific Neuromodulation and Neurostimulation Pain Management Devices Consumption Value by Region (2019-2030)
    • 8.3.2 China Neuromodulation and Neurostimulation Pain Management Devices Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Neuromodulation and Neurostimulation Pain Management Devices Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Neuromodulation and Neurostimulation Pain Management Devices Market Size and Forecast (2019-2030)
    • 8.3.5 India Neuromodulation and Neurostimulation Pain Management Devices Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Neuromodulation and Neurostimulation Pain Management Devices Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Neuromodulation and Neurostimulation Pain Management Devices Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Neuromodulation and Neurostimulation Pain Management Devices Consumption Value by Type (2019-2030)
  • 9.2 South America Neuromodulation and Neurostimulation Pain Management Devices Consumption Value by Application (2019-2030)
  • 9.3 South America Neuromodulation and Neurostimulation Pain Management Devices Market Size by Country
    • 9.3.1 South America Neuromodulation and Neurostimulation Pain Management Devices Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Neuromodulation and Neurostimulation Pain Management Devices Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Neuromodulation and Neurostimulation Pain Management Devices Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Neuromodulation and Neurostimulation Pain Management Devices Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Neuromodulation and Neurostimulation Pain Management Devices Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Neuromodulation and Neurostimulation Pain Management Devices Market Size by Country
    • 10.3.1 Middle East & Africa Neuromodulation and Neurostimulation Pain Management Devices Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Neuromodulation and Neurostimulation Pain Management Devices Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Neuromodulation and Neurostimulation Pain Management Devices Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Neuromodulation and Neurostimulation Pain Management Devices Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Neuromodulation and Neurostimulation Pain Management Devices Market Drivers
  • 11.2 Neuromodulation and Neurostimulation Pain Management Devices Market Restraints
  • 11.3 Neuromodulation and Neurostimulation Pain Management Devices Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Neuromodulation and Neurostimulation Pain Management Devices Industry Chain
  • 12.2 Neuromodulation and Neurostimulation Pain Management Devices Upstream Analysis
  • 12.3 Neuromodulation and Neurostimulation Pain Management Devices Midstream Analysis
  • 12.4 Neuromodulation and Neurostimulation Pain Management Devices Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Neuromodulation and Neurostimulation Pain Management Devices. Industry analysis & Market Report on Neuromodulation and Neurostimulation Pain Management Devices is a syndicated market report, published as Global Neuromodulation and Neurostimulation Pain Management Devices Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Neuromodulation and Neurostimulation Pain Management Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,634.36
    		3,951.54
    		5,268.72
    		3,132.00
    		4,698.00
    		6,264.00
    		494,682.00
    		742,023.00
    		989,364.00
    		291,380.40
    		437,070.60
    		582,760.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo